after control (nonsupplemented) tests, nine healthy, physically active male subjects were assigned in a randomized, double-blind, crossover design to receive br (0.5 l/day, containing ∼6.2 mmol of no(3)(-)) and pl (0.5 l/day, containing ∼0.003 mmol of no(3)(-)) for 6 days.